About us
The Team
Aurélien Rizk
CEO
PhD in Computer Science
10 years experience in systems biology.
Jenny Hao
Head of Business Development and Marketing
Senior Executive with strong entrepreneurial spirit.
20 years experience in global pharmaceutical and Medtech companies across Europe, Asia, and the USA.
Luca Zenone
CFO & COO
MSc in Business
Administration running all the finance, legal and operations of the company.
Mirjam Zimmermann
HEAD OF RESEARCH
PhD in Biochemistry
6 years cellular biology, cell signaling and pharmacology.
Yaroslav Nikolaev
HEAD OF COMPUTATIONAL SCIENCE
PhD with dual Biology-MSc Computation-MSc background
12 years research experience in structural and systems biology.
Jens Kurth
HEAD OF DRUG DEVELOPMENT
PhD in Biochemistry
25 years experience driving the development, regulatory approval and commercialization of new drugs.
Susanne Roth
PRINCIPAL SCIENCIST SYSTEMS BIOLOGY
PhD in Systems Biology
6 years GPCR signaling and mathematical modeling.
Tomek Stepniewski
SCIENTIST COMPUTATIONAL CHEMISTRY
PhD in Biomedicine
Agne Tilunaite
SCIENTIST SYSTEM BIOLOGY
PhD in Mathematical Medicine and Biology
Nadine Dobberstein
LABORATORY TECHNICIAN
MSc Quantitative and Systems Biology
Mierelle Schuijt
LABORATORY TECHNICIAN
MSc Biomolecular Sciences
Kylie Pan
PhD STUDENT
MSc Experimental Pharmacology and Therapeutics
Prof. Dr. Jens Gobrecht
Prof. Dr. Jens Gobrecht
HEAD OF BOARD OF DIRECTORS
Prof. emeritus Laboratory for Micro- and Nanotechnology at the Paul Scherrer Institute (PSI); Co-founder of EULITHA AG; Honorary Member of the Swiss Nanoscience Institute
Dr. Aurélien Rizk
Dr. Aurélien Rizk
BOARD MEMBER
PhD Computer Science; Co-Founder and CEO InterAx Biotech; Co-Founder Algorizk
Luca Zenone
Luca Zenone
BOARD MEMBER
MSc ETH Management, Technology and Economics; Engineering and Management Consulting; Co-Founder, CFO and COO InterAx Biotech
Dr. Yiannis Monovoukas
Dr. Yiannis Monovoukas
BOARD MEMBER
Managing Partner, Falcon III and SpringTide Ventures Fund I; CEO, Helios Cardiovascular and AuraGen Aesthetics
Dr. Bettina Ernst
Dr. Bettina Ernst
BOARD MEMBER
CEO of PRECLIN Biosystems; Board member of multiple biotech companies; VP of Board of Swiss Biotech Association
Prof. Gebhard Schertler
Prof. Gebhard Schertler
HEAD OF SCIENTIFIC ADVISORY BOARD
Professor for Structural Biology ETH Zürich; Head of Biology and Chemistry at the Paul Scherrer Institute (PSI)
Dr. Chris de Graaf
Dr. Chris de Graaf
SCIENTIFIC ADVISOR
Director of Computational Chemistry, Heptares Therapeutics
Prof. Michel Bouvier
Prof. Michel Bouvier
SCIENTIFIC ADVISOR
Professor for Biochemistry Université de Montréal; CEO Institute for Research in Immunology and Cancer (IRICoR), Montreal
Dr. Jana Selent
Dr. Jana Selent
SCIENTIFIC ADVISOR
Associate Professor & Miguel Servet Researcher Research Group on Biomedical Informatics (GRIB) Hospital del Mar Medical Research Institute (IMIM) DCEXS, Pompeu Fabra University (UPF)
Prof. Ruedi Aebersold
Prof. Ruedi Aebersold
SCIENTIFIC ADVISOR
Pioneer in the field of proteomics and systems biology
Dr. Philipp Berger
Dr. Philipp Berger
SCIENTIFIC ADVISOR
Senior Scientist, Paul Scherrer Institute (PSI)
Prof. Stuart Maudsley
Prof. Stuart Maudsley
SCIENTIFIC ADVISOR
Odysseus Professor of Receptor Pharmacology at Uni of Antwerpen. He leads a multidisciplinary team to understand the molecular signaling architecture of complex aging-related diseases.
Our Story
2010
2010
During his PhD at the Paul Scherrer Institute, Martin Ostermaier plants the "Arrestin" seed of InterAx
2011
During his PostDoc at the Paul Scherrer Institute, Aurßelien Rizk plants the "Systems Biology" seed of InterAx
2014
2014
After his MSc in Management Technology and Economics, Lucas Zenone plants the "Business" seed of InterAx
August 2014
The project receives 150k CHF from the ETH Foundation
